LAMEA Anti-Obesity Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Mechanism of Action, By Route Of Administration (Oral Route and Subcutaneous Route), By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

The Latin America, Middle East and Africa Anti-Obesity Drugs Market would witness market growth of 14.9% CAGR during the forecast period (2023-2029).

Prescription drugs can aid in weight loss and maintenance for certain people when accompanied by behavioral modifications like healthier eating and increased exercise. People who use prescription drugs in conjunction with a lifestyle program typically lose more of their beginning body weight after a year than those who do not use prescription drugs. Some persons who use prescription weight-management drugs see a weight loss of 10% or more compared to their beginning weight. By lowering blood pressure, blood sugar, and lipid levels, weight loss of 5% to 10% of the initial body weight may assist the person's health. Additionally, certain additional health issues linked to being overweight or obese, like joint pain and sleep apnea, can be improved by losing weight. Within the first six months of using the medicine, most weight loss occurs.

The estimated range of diabetes prevalence in Saudi Arabia was between 9% and 22% from 1980 to 2008. It is estimated that there are approximately 7 million individuals with diabetes and an additional 3 million in the prediabetic phase. The prevalence of this region is being impacted by various factors, including unhealthy lifestyles, genetic susceptibility, and an increase in the incidence of type 2 diabetes mellitus among young adults and children. The rise in diabetes is anticipated to boost the utilization of anti-obesity drugs as they are efficient in countering diabetic illness, especially in people who are also suffering from obesity, increasing the market growth in the region.

The Brazil market dominated the LAMEA Anti-Obesity Drugs Market by Country in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $64.5 million by 2029. The Argentina market is experiencing a CAGR of 15.5% during (2023 - 2029). Additionally, The UAE market would display a CAGR of 14.6% during (2023 - 2029).

Based on Drug Type, the market is segmented into Prescription Drugs and Over The Counter Drugs. Based on Mechanism of Action, the market is segmented into Centrally Acting and Peripherally Acting. Based on Route Of Administration, the market is segmented into Oral Route and Subcutaneous Route. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Worldwide Anti-Obesity Drugs Market is Projected to reach USD 3.1 Billion by 2029, at a CAGR of 10.6%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Pfizer, Inc., Boehringer Ingelheim International GmbH, GlaxoSmithKline PLC, Novo Nordisk A/S, Rhythm Pharmaceuticals, Inc., Gelesis Holdings Inc. (PureTech Health), Currax Pharmaceuticals LLC (Currax Holdings USA LLC), Vivus LLC, CHEPLAPHARM Arzneimittel GmbH (Braun Beteiligungs GmbH) and KVK Tech, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Drug Type

• Prescription Drugs
• Over The Counter Drugs

By Mechanism of Action

• Centrally Acting
• Peripherally Acting

By Route Of Administration

• Oral Route
• Subcutaneous Route

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Pfizer, Inc.
• Boehringer Ingelheim International GmbH
• GlaxoSmithKline PLC
• Novo Nordisk A/S
• Rhythm Pharmaceuticals, Inc.
• Gelesis Holdings Inc. (PureTech Health)
• Currax Pharmaceuticals LLC (Currax Holdings USA LLC)
• Vivus LLC
• CHEPLAPHARM Arzneimittel GmbH (Braun Beteiligungs GmbH)
• KVK Tech, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Anti-Obesity Drugs Market, by Drug Type
1.4.2 LAMEA Anti-Obesity Drugs Market, by Mechanism of Action
1.4.3 LAMEA Anti-Obesity Drugs Market, by Route Of Administration
1.4.4 LAMEA Anti-Obesity Drugs Market, by Distribution Channel
1.4.5 LAMEA Anti-Obesity Drugs Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. LAMEA Anti-Obesity Drugs Market by Drug Type
3.1 LAMEA Prescription Drugs Market by Country
3.2 LAMEA Over The Counter Drugs Market by Country

Chapter 4. LAMEA Anti-Obesity Drugs Market by Mechanism of Action
4.1 LAMEA Centrally Acting Market by Country
4.2 LAMEA Peripherally Acting Market by Country

Chapter 5. LAMEA Anti-Obesity Drugs Market by Route Of Administration
5.1 LAMEA Oral Route Market by Country
5.2 LAMEA Subcutaneous Route Market by Country

Chapter 6. LAMEA Anti-Obesity Drugs Market by Distribution Channel
6.1 LAMEA Hospital Pharmacies Market by Country
6.2 LAMEA Retail Pharmacies Market by Country
6.3 LAMEA Online Pharmacies Market by Country

Chapter 7. LAMEA Anti-Obesity Drugs Market by Country
7.1 Brazil Anti-Obesity Drugs Market
7.1.1 Brazil Anti-Obesity Drugs Market by Drug Type
7.1.2 Brazil Anti-Obesity Drugs Market by Mechanism of Action
7.1.3 Brazil Anti-Obesity Drugs Market by Route Of Administration
7.1.4 Brazil Anti-Obesity Drugs Market by Distribution Channel
7.2 Argentina Anti-Obesity Drugs Market
7.2.1 Argentina Anti-Obesity Drugs Market by Drug Type
7.2.2 Argentina Anti-Obesity Drugs Market by Mechanism of Action
7.2.3 Argentina Anti-Obesity Drugs Market by Route Of Administration
7.2.4 Argentina Anti-Obesity Drugs Market by Distribution Channel
7.3 UAE Anti-Obesity Drugs Market
7.3.1 UAE Anti-Obesity Drugs Market by Drug Type
7.3.2 UAE Anti-Obesity Drugs Market by Mechanism of Action
7.3.3 UAE Anti-Obesity Drugs Market by Route Of Administration
7.3.4 UAE Anti-Obesity Drugs Market by Distribution Channel
7.4 Saudi Arabia Anti-Obesity Drugs Market
7.4.1 Saudi Arabia Anti-Obesity Drugs Market by Drug Type
7.4.2 Saudi Arabia Anti-Obesity Drugs Market by Mechanism of Action
7.4.3 Saudi Arabia Anti-Obesity Drugs Market by Route Of Administration
7.4.4 Saudi Arabia Anti-Obesity Drugs Market by Distribution Channel
7.5 South Africa Anti-Obesity Drugs Market
7.5.1 South Africa Anti-Obesity Drugs Market by Drug Type
7.5.2 South Africa Anti-Obesity Drugs Market by Mechanism of Action
7.5.3 South Africa Anti-Obesity Drugs Market by Route Of Administration
7.5.4 South Africa Anti-Obesity Drugs Market by Distribution Channel
7.6 Nigeria Anti-Obesity Drugs Market
7.6.1 Nigeria Anti-Obesity Drugs Market by Drug Type
7.6.2 Nigeria Anti-Obesity Drugs Market by Mechanism of Action
7.6.3 Nigeria Anti-Obesity Drugs Market by Route Of Administration
7.6.4 Nigeria Anti-Obesity Drugs Market by Distribution Channel
7.7 Rest of LAMEA Anti-Obesity Drugs Market
7.7.1 Rest of LAMEA Anti-Obesity Drugs Market by Drug Type
7.7.2 Rest of LAMEA Anti-Obesity Drugs Market by Mechanism of Action
7.7.3 Rest of LAMEA Anti-Obesity Drugs Market by Route Of Administration
7.7.4 Rest of LAMEA Anti-Obesity Drugs Market by Distribution Channel

Chapter 8. Company Profiles
8.1 Pfizer, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional & Segmental Analysis
8.1.4 Research & Development Expense
8.2 Boehringer Ingelheim International Gmbh
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional & Segmental Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 GlaxoSmithKline PLC (GSK)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.4 Novo Nordisk A/S
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental & Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Approvals and Trials:
8.5 Rhythm Pharmaceuticals, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Research & Development Expenses
8.6 Gelesis Holdings Inc (PureTech Health)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expenses
8.6.4 Recent strategies and developments:
8.6.4.1 Partnerships, Collaborations, and Agreements:
8.6.4.2 Approvals and Trials:
8.7 Currax Pharmaceuticals LLC (Currax Holdings USA LLC)
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Acquisition and Mergers:
8.8 Vivus LLC
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Approvals and Trials:
8.9 CHEPLAPHARM Arzneimittel GmbH (Braun Beteiligungs GmbH)
8.9.1 Company Overview
8.10. KVK Tech, Inc.
8.10.1 Company Overview

TABLE 1 LAMEA Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 2 LAMEA Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 3 LAMEA Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 4 LAMEA Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 5 LAMEA Prescription Drugs Market by Country, 2019 - 2022, USD Million
TABLE 6 LAMEA Prescription Drugs Market by Country, 2023 - 2029, USD Million
TABLE 7 LAMEA Over The Counter Drugs Market by Country, 2019 - 2022, USD Million
TABLE 8 LAMEA Over The Counter Drugs Market by Country, 2023 - 2029, USD Million
TABLE 9 LAMEA Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 10 LAMEA Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 11 LAMEA Centrally Acting Market by Country, 2019 - 2022, USD Million
TABLE 12 LAMEA Centrally Acting Market by Country, 2023 - 2029, USD Million
TABLE 13 LAMEA Peripherally Acting Market by Country, 2019 - 2022, USD Million
TABLE 14 LAMEA Peripherally Acting Market by Country, 2023 - 2029, USD Million
TABLE 15 LAMEA Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 16 LAMEA Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 17 LAMEA Oral Route Market by Country, 2019 - 2022, USD Million
TABLE 18 LAMEA Oral Route Market by Country, 2023 - 2029, USD Million
TABLE 19 LAMEA Subcutaneous Route Market by Country, 2019 - 2022, USD Million
TABLE 20 LAMEA Subcutaneous Route Market by Country, 2023 - 2029, USD Million
TABLE 21 LAMEA Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 22 LAMEA Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 23 LAMEA Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 24 LAMEA Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 25 LAMEA Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 26 LAMEA Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 27 LAMEA Online Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 28 LAMEA Online Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 29 LAMEA Anti-Obesity Drugs Market by Country, 2019 - 2022, USD Million
TABLE 30 LAMEA Anti-Obesity Drugs Market by Country, 2023 - 2029, USD Million
TABLE 31 Brazil Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 32 Brazil Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 33 Brazil Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 34 Brazil Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 35 Brazil Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 36 Brazil Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 37 Brazil Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 38 Brazil Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 39 Brazil Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 40 Brazil Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 41 Argentina Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 42 Argentina Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 43 Argentina Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 44 Argentina Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 45 Argentina Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 46 Argentina Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 47 Argentina Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 48 Argentina Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 49 Argentina Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 50 Argentina Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 51 UAE Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 52 UAE Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 53 UAE Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 54 UAE Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 55 UAE Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 56 UAE Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 57 UAE Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 58 UAE Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 59 UAE Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 60 UAE Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 61 Saudi Arabia Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 62 Saudi Arabia Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 63 Saudi Arabia Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 64 Saudi Arabia Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 65 Saudi Arabia Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 66 Saudi Arabia Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 67 Saudi Arabia Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 68 Saudi Arabia Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 69 Saudi Arabia Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 70 Saudi Arabia Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 71 South Africa Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 72 South Africa Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 73 South Africa Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 74 South Africa Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 75 South Africa Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 76 South Africa Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 77 South Africa Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 78 South Africa Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 79 South Africa Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 80 South Africa Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 81 Nigeria Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 82 Nigeria Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 83 Nigeria Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 84 Nigeria Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 85 Nigeria Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 86 Nigeria Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 87 Nigeria Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 88 Nigeria Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 89 Nigeria Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 90 Nigeria Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 91 Rest of LAMEA Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 92 Rest of LAMEA Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 93 Rest of LAMEA Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 94 Rest of LAMEA Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 95 Rest of LAMEA Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 96 Rest of LAMEA Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 97 Rest of LAMEA Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 98 Rest of LAMEA Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 99 Rest of LAMEA Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 100 Rest of LAMEA Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 101 Key Information – Pfizer, Inc.
TABLE 102 Key Information – Boehringer Ingelheim International GmbH
TABLE 103 Key Information – GlaxoSmithKline PLC (GSK)
TABLE 104 Key information – Novo Nordisk A/S
TABLE 105 Key Information – Rhythm Pharmaceuticals, Inc
TABLE 106 Key Information – Gelesis Holdings Inc.
TABLE 107 Key Information – Currax Pharmaceuticals LLC
TABLE 108 Key Information – Vivus LLC
TABLE 109 Key Information – CHEPLAPHARM Arzneimittel GmbH
TABLE 110 Key Information – KVK Tech, Inc.

List of Figures
FIG 1 Methodology for the research